DigitalGlassware ® to be adopted by the University of Nottingham's School of Chemistry to support the development of machine learning models of sustainable chemistry DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, is delighted to be collaborating again with the University of Nottingham's School of Chemistry, providing access to the DigitalGlassware® platform to [...]

Newomics Inc., a biotechnology company developing and commercializing mass spectrometry solutions, today announced that it has established a North America Sales Team, and it is launching a new product to enhance the existing mass spectrometry workflows. Newomics continues its dedication to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. [...]

Funding will accelerate company growth and infrastructure expansion leading up to full commercial launch Vizgen, the life science company dedicated to advancing human health by visualizing single-cell spatial genomics information, has closed a $37 million Series B financing. The financing was co-led by Novalis LifeSciences LLC, and current investor Northpond Ventures. Also participating in the round were [...]

CDD Awarded $1.5M Phase 2 SBIR Grant on an Intelligent Chemical Structure Browser for Drug Discovery and Optimization Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer-reviewed Phase 2 SBIR grant from NIH NCATS, titled: “Intelligent Chemical Structure Browser for Drug Discovery and Optimization”. This [...]

QIAseq DIRECT SARS-CoV-2 Kit halves both library preparation times and plasticware use Kit supports analysis of over 6,000 samples simultaneously on highest-throughput sequencers Integrates with QIAGEN Digital Insights cloud solutions to support variant detection and reporting including clade and lineage annotations across sequencing platforms GERMANTOWN, Md. & HILDEN, Germany --  QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime [...]

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.  The transaction included initial consideration of $215 million in cash plus contingent consideration of up to $105 million upon the achievement of certain future milestones.  The Asuragen acquisition adds a leading portfolio of best-in-class molecular diagnostic and research products, [...]

WATERTOWN, Mass.-- Captivate Bio, a scientific cell culture solutions provider headquartered in Watertown, Massachusetts, announced today it has signed a distribution agreement with denovoMATRIX GmbH, a biotechnology company located in Dresden, Germany which designs modular, biomimetic coatings for adherent cell manufacturing. Captivate Bio will become the North American distributor of myMATRIX products including the innovative [...]

CELLINK entered a collaboration with UPM Biomedicals in March which is now running according to plan. The partnership brings together UPM:s expertise for producing non-animal derived, nanocellulose biomaterials with CELLINK’s years of experience in method development for 3D bioprinting, offering new ground-breaking solutions to this growing life sciences market. Advances in 3D printing in the [...]

ABEC Custom Single Run (CSR) systems supplied on fast-track schedule to support flexible manufacturing of plasmid DNA Bethlehem, PA, USA – ABEC, a leading global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that it has supplied two 50L CSR single-use fermenters to Catalent Cell & Gene Therapy. The custom designed systems were delivered on an accelerated [...]

GUILDFORD, United Kingdom -- LabVoice, which provides a workflow engine for scientific voice assistants, and IDBS, a leading R&D technology and solutions provider, are excited to announce an integration to accelerate research, innovation, and design. By introducing voice to IDBS scientific software platforms, scientists will have real-time access to their ELN, regardless of their location in [...]